Table 3 Statistical analysis of the results of antimicrobial susceptibility to 23 antibiotics for 54Â S. flexneri
Antibiotic | Antimicrobial resistance rate No. (%) | |||||
|---|---|---|---|---|---|---|
Total (n = 54) | Gansu (n = 37) | Shanxi (n = 8) | Xinjiang (n = 2) | Qinghai (n = 5) | Tibet (n = 2) | |
Penicillin G (P) | 54 (100%) | 37 (100%) | 8 (100%) | 2 (100%) | 5 (100%) | 2 (100%) |
Ampicillin (AMP) | 51 (94.44%) | 37 (100%) | 8 (100%) | 2 (100%) | 3 (60%) | 1 (50%) |
Amoxycillin/Clavulanic acid (AMC) | 5 (9.62%) | 3 (8.11%) | 1 (12.5%) | 1 (50%) | 0 | 0 |
Cephalothin (KF) | 29 (53.70%) | 19 (51.35%) | 5 (62.5%) | 2 (100%) | 2 (40%) | 1 (50%) |
Cephazolin (KZ) | 34 (62.96%) | 21 (56.76%) | 7 (87.5%) | 2 (100%) | 3 (60%) | 1 (50%) |
Cefamandole (MA) | 16 (29.63%) | 12 (32.43%) | 2 (25%) | 1 (50%) | 1 (20%) | 0 |
Cefoxitin (FOX) | 3 (5.56%) | 2 (5.41%) | 1 (12.5%) | 0 | 0 | 0 |
Ceftriaxone (CRO) | 12 (22.22%) | 9 (24.32%) | 2 (25%) | 1 (50%) | 0 | 0 |
Cefotaxime (CTX) | 14 (25.93%) | 10 (27.03%) | 2 (25%) | 1 (50%) | 1 (20%) | 0 |
Cefoperazone (CFP) | 6 (11.11%) | 6 (16.22%) | 0 | 0 | 0 | 0 |
Cefepime (FEP) | 0 | 0 | 0 | 0 | 0 | 0 |
Meropenem (MEM) | 0 | 0 | 0 | 0 | 0 | 0 |
Imipenem (IPM) | 0 | 0 | 0 | 0 | 0 | 0 |
Norfloxacin (NOR) | 16 (29.63%) | 12 (32.43%) | 3 (37.5%) | 1 (50%) | 0 | 0 |
Enrofloxacin (ENR) | 13(24.07%) | 11 (29.73%) | 2 (25%) | 0 | 0 | 0 |
Levofloxacin (LEV) | 14 (25.93%) | 11 (29.73%) | 2 (25%) | 1 (50%) | 0 | 0 |
Ciprofloxacin (CIP) | 2 (3.70%) | 2 (5.41%) | 0 | 0 | 0 | 0 |
Erythromycin (E) | 46 (85.19%) | 35 (94.59%) | 6 (75%) | 2 (100%) | 3 (60%) | 0 |
Tetracycline (TE) | 49 (90.74%) | 35 (94.59%) | 8 (100%) | 2 (100%) | 3 (60%) | 1 (50%) |
Chloramphenicol (C) | 17 (31.48%) | 10 (27.03%) | 6 (75%) | 1 (50%) | 0 | 0 |
Streptomycin (S) | 38 (70.37%) | 30 (81.08%) | 4 (50%) | 2 (100%) | 2 (40%) | 0 |
Gentamicin (CN) | 29 (53.70%) | 23 (62.16%) | 4 (50%) | 2 (100%) | 0 | 0 |
Amikacin (AK) | 3 (5.56%) | 3 (8.11%) | 0 | 0 | 0 | 0 |